Cirrhosis News and Research

Latest Cirrhosis News and Research

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with cure rates above 95%.

21 May 2021

Researchers link “genetic signatures” of bacteria in the human gut to multiple diseases

We are truly never alone, not even within our own bodies. Human beings play host to trillions of bacteria, fungi, viruses, and other microorganisms that make up the human microbiome.

18 May 2021

UCL scientists identify new immunotherapy to combat hepatitis B virus

Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.

14 May 2021

Study suggests GILZ protein as a promising anti-hepatic fibrosis drug target

Scientists from Russia and Italy studied a new axis of the pathway that prevents the development of liver fibrosis. The role of GILZ protein in curbing the disease progression was shown in a study using mice models and confirmed by clinical data.

5 May 2021

New study launched to more accurately diagnose early hepatocellular carcinoma

A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual's likelihood of developing the cancer.

3 May 2021

New approach could revolutionize the treatment of liver diseases

Researchers from Niigata University , the University of Tokyo, Osaka University and Tokyo Medical University, Japan have developed a new approach that could revolutionize the treatment, prevention, and possibly reversal of the damages caused by liver diseases.

3 May 2021

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH). PoPH occurs in approximately 15% of patients with PAH, and is reportedly found in 2-6% of patients with portal hypertension and 1-2% of patients with liver cirrhosis according to studies from Europe and America.

27 Apr 2021

Researchers test whether feces transplantation can help patients with cirrhosis of the liver

Researchers from Aarhus University and Aarhus University Hospital replace sick intestinal bacteria with intestinal bacteria from healthy donors in a treatment intended to help patients with cirrhosis of the liver. The Novo Nordisk Foundation supports the project with just over DKK 13 million.

19 Apr 2021

Expanding risk assessment parameters improves prediction of waitlist mortality for liver transplants

The top priority in the field of transplantation is to ensure that donor organs are allocated to the patients with the greatest need.

13 Apr 2021

Researchers reveal the positive effects of exercise on the liver

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide, affecting as much as a quarter of humanity. It is characterized by fat accumulation in liver cells and may progress to inflammation, cirrhosis and liver failure.

12 Apr 2021

Research consortium identifies cell stress mechanisms for chronic inflammatory liver disease

Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat, since its causes have not yet been adequately researched.

30 Mar 2021

Bariatric surgery can reduce the risk of obesity-related cancers, study shows

Bariatric surgery can significantly reduce the risk of cancer--and especially obesity-related cancers--by as much as half in certain individuals, according to a study by researchers at Rutgers Robert Wood Johnson Medical School's Center for Liver Diseases and Liver Masses.

26 Mar 2021

Simple blood test using nanoparticles could enable earlier detection of acute liver damage

University of Texas at Dallas chemist Dr. Jie Zheng has spent much of his career investigating gold nanoparticles for their potential impact in the field of nanomedicine.

10 Mar 2021

Ultrasound elastography do not show the actual status of postoperative liver fibrosis

It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due partly to the need for an accurate diagnostic method.

8 Mar 2021

Alcohol and tobacco sales nationwide rose in the early months of COVID-19

COVID-19 has taken a huge medical, emotional and economic toll on Americans. Now, new Keck Medicine of USC research shows that the pandemic may also have harmful indirect consequences.

1 Mar 2021

Current screening guidelines may not detect liver cancer soon enough in African Americans

Early detection could reduce the number of African Americans dying from liver cancer, but current screening guidelines may not find cancer soon enough in this community, according to a study published in Cancer in February.

25 Feb 2021

Researchers study geographical distribution of mortality from 16 causes in Spain

Miguel ángel Martínez, professor at the Faculty of Mathematics of the University of Valencia (UV) is the coordinator of MEDEA3, a statistical study on the geographical distribution of mortality from 16 causes in 26 Spanish cities of 11 autonomous communities.

22 Feb 2021

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.

15 Feb 2021

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

As the pandemic sends thousands of recovering alcoholics into relapse, hospitals across the country have reported dramatic increases in alcohol-related admissions for critical diseases like alcoholic hepatitis and liver failure.

10 Feb 2021

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders

Senescent cells accumulate in organs during aging, promote tissue dysfunction, and cause numerous aging-related diseases like cancer. The cells arise through a process called "cellular senescence," a permanent cell cycle arrest resulting from multiple stresses.

5 Feb 2021

Cirrhosis News and Research

Latest Cirrhosis News and Research

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Researchers link “genetic signatures” of bacteria in the human gut to multiple diseases

UCL scientists identify new immunotherapy to combat hepatitis B virus

Study suggests GILZ protein as a promising anti-hepatic fibrosis drug target

New study launched to more accurately diagnose early hepatocellular carcinoma

New approach could revolutionize the treatment of liver diseases

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Researchers test whether feces transplantation can help patients with cirrhosis of the liver

Expanding risk assessment parameters improves prediction of waitlist mortality for liver transplants

Researchers reveal the positive effects of exercise on the liver

Research consortium identifies cell stress mechanisms for chronic inflammatory liver disease

Bariatric surgery can reduce the risk of obesity-related cancers, study shows

Simple blood test using nanoparticles could enable earlier detection of acute liver damage

Ultrasound elastography do not show the actual status of postoperative liver fibrosis

Alcohol and tobacco sales nationwide rose in the early months of COVID-19

Current screening guidelines may not detect liver cancer soon enough in African Americans

Researchers study geographical distribution of mortality from 16 causes in Spain

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cirrhosis News and Research

Latest Cirrhosis News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in